Correlation Between OncoVista Innovative and BioCardia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OncoVista Innovative and BioCardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoVista Innovative and BioCardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoVista Innovative Therapies and BioCardia, you can compare the effects of market volatilities on OncoVista Innovative and BioCardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoVista Innovative with a short position of BioCardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoVista Innovative and BioCardia.

Diversification Opportunities for OncoVista Innovative and BioCardia

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between OncoVista and BioCardia is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding OncoVista Innovative Therapies and BioCardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCardia and OncoVista Innovative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoVista Innovative Therapies are associated (or correlated) with BioCardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCardia has no effect on the direction of OncoVista Innovative i.e., OncoVista Innovative and BioCardia go up and down completely randomly.

Pair Corralation between OncoVista Innovative and BioCardia

Given the investment horizon of 90 days OncoVista Innovative is expected to generate 15.5 times less return on investment than BioCardia. But when comparing it to its historical volatility, OncoVista Innovative Therapies is 9.37 times less risky than BioCardia. It trades about 0.05 of its potential returns per unit of risk. BioCardia is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  73.00  in BioCardia on November 2, 2024 and sell it today you would lose (73.00) from holding BioCardia or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy43.06%
ValuesDaily Returns

OncoVista Innovative Therapies  vs.  BioCardia

 Performance 
       Timeline  
OncoVista Innovative 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in OncoVista Innovative Therapies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent forward indicators, OncoVista Innovative unveiled solid returns over the last few months and may actually be approaching a breakup point.
BioCardia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioCardia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BioCardia is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

OncoVista Innovative and BioCardia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OncoVista Innovative and BioCardia

The main advantage of trading using opposite OncoVista Innovative and BioCardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoVista Innovative position performs unexpectedly, BioCardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCardia will offset losses from the drop in BioCardia's long position.
The idea behind OncoVista Innovative Therapies and BioCardia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing